Literature DB >> 9294096

Aspirin use and potential mechanisms for colorectal cancer prevention.

C S Williams1, W Smalley, R N DuBois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9294096      PMCID： PMC508309          DOI： 10.1172/JCI119651

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  44 in total

1.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

Authors:  H Sano; Y Kawahito; R L Wilder; A Hashiramoto; S Mukai; K Asai; S Kimura; H Kato; M Kondo; T Hla
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

2.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

Authors:  M Tsujii; R N DuBois
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

Review 3.  The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.

Authors:  F M Giardiello; G J Offerhaus; R N DuBois
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

4.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

Authors:  C E Eberhart; R J Coffey; A Radhika; F M Giardiello; S Ferrenbach; R N DuBois
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

5.  Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.

Authors:  S J Shiff; M I Koutsos; L Qiao; B Rigas
Journal:  Exp Cell Res       Date:  1996-01-10       Impact factor: 3.905

6.  Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Authors:  G A Piazza; A L Rahm; M Krutzsch; G Sperl; N S Paranka; P H Gross; K Brendel; R W Burt; D S Alberts; R Pamukcu
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

Review 7.  Prostaglandin endoperoxide synthase: why two isoforms?

Authors:  C S Williams; R N DuBois
Journal:  Am J Physiol       Date:  1996-03

8.  Aspirin and the risk of colorectal cancer in women.

Authors:  E Giovannucci; K M Egan; D J Hunter; M J Stampfer; G A Colditz; W C Willett; F E Speizer
Journal:  N Engl J Med       Date:  1995-09-07       Impact factor: 91.245

9.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

Authors:  S L Kargman; G P O'Neill; P J Vickers; J F Evans; J A Mancini; S Jothy
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

10.  Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.

Authors:  R N DuBois; A Radhika; B S Reddy; A J Entingh
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682
View more
  49 in total

1.  Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers.

Authors:  Hui-Hua Chang; Zuohe Song; Lee Wisner; Tina Tripp; Vijay Gokhale; Emmanuelle J Meuillet
Journal:  Invest New Drugs       Date:  2011-09-20       Impact factor: 3.850

2.  Sporadic adenomatous polyp regression with exisulind is effective but toxic: a randomised, double blind, placebo controlled, dose-response study.

Authors:  N Arber; S Kuwada; M Leshno; R Sjodahl; R Hultcrantz; D Rex
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 3.  Nitric oxide-releasing NSAIDs: a review of their current status.

Authors:  S Fiorucci; E Antonelli; J L Burgaud; A Morelli
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Role of Helicobacter pylori in gastric cancer: Updates.

Authors:  Jahanarah Khatoon; Ravi Prakash Rai; Kashi Nath Prasad
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 5.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

6.  Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis.

Authors:  Arpita Roy; Miaojun Zhang; Yasser Saad; Pappachan E Kolattukudy
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-18       Impact factor: 4.249

7.  Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma.

Authors:  Wei Li; Ru-jun Xu; Li-hui Jiang; Jingfeng Shi; Xiang Long; Bei Fan
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 8.  [Clinical pharmacology of the selective COX-2 inhibitors].

Authors:  M Burian; G Geisslinger
Journal:  Orthopade       Date:  2003-12       Impact factor: 1.087

9.  Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).

Authors:  Mark Nelson; Christopher Reid; Lawrence Beilin; Geoffrey Donnan; Colin Johnston; Henry Krum; Elsdon Storey; Andrew Tonkin; John McNeil
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Abnormal growth factor/cytokine network in gastric cancer.

Authors:  Eiichi Tahara
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.